KIF23 and glioma: KIF23 overexpression was found in lung cancer cells, and its downregulation caused a cytokinesis defect and decreased the proliferation of glioma cells 79, 80, and NDC80 serves as a potential therapeutic target in lung adenocarcinoma 81.